GNH USA

Europe — EMA

Oliclinomel N8-800

GNH USA supplies Oliclinomel N8-800 (amino acids), a parenteral nutrition supplement for patients unable to receive enteral feeding or needing protein

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin

Request sourcing

1
Pack/s

What is Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin?

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Oliclinomel N8-800, is a amino acid supplement presented as a parenteral nutrition intravenous solution for intravenous use. It supports protein synthesis and metabolic needs in patients who cannot receive enteral feeding.

GNH USA supplies Oliclinomel N8-800 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin used for?

Oliclinomel N8-800, an amino acid solution used in parenteral nutrition, addresses several clinical situations: - Parenteral nutrition (enteral feeding intolerance): Provides essential amino acids for patients who cannot receive enteral nutrition. - Post‑operative care (surgical recovery): Supports protein synthesis and nitrogen balance after major surgery. - Critical illness (intensive care): Supplies amino acids to critically ill patients to maintain metabolic function.

What are the side effects of Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin?

Adverse reactions may occur with intravenous amino acid solutions.

Common Side Effects: - Electrolyte imbalance: mild shifts in sodium, potassium or calcium levels. - Hyperglycemia: transient rise in blood glucose during infusion. - Mild nausea or vomiting: occasional gastrointestinal discomfort. - Local infusion site irritation: redness or discomfort at the catheter site.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate intervention. - Severe metabolic acidosis: significant pH changes in blood. - Renal dysfunction: impaired kidney function in susceptible patients. - Thrombophlebitis: inflammation and clot formation in the vein.

What precautions apply to Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin?

When using Oliclinomel N8-800, consider the following precautions: - Renal impairment: monitor renal function and adjust infusion rate. - Liver disease: use with caution due to altered amino acid metabolism. - Electrolyte disorders: correct existing imbalances before administration. - Hyperammonemia: avoid in patients with urea cycle defects. - Pregnancy: limited data; weigh benefits against potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin interact with?

Potential drug interactions should be reviewed before initiating therapy.

Major Interactions (Avoid): - Concurrent high‑dose amino acid solutions: risk of nitrogen overload. - Incompatible IV solutions containing calcium or phosphate: precipitation risk.

Moderate Interactions (Monitor Closely): - Insulin therapy: may require dose adjustment due to glucose changes. - Diuretics: monitor electrolyte balance closely. - Renal replacement therapy: may affect amino acid clearance and require dosing review.

Frequently asked questions

What is Oliclinomel N8-800 used for?+
Oliclinomel N8-800 is an intravenous amino acid solution used as part of parenteral nutrition. It provides essential amino acids to patients who cannot receive enteral feeding, supports protein synthesis after surgery, and helps maintain metabolic balance in critically ill individuals.
How does the amino acid blend in Oliclinomel N8-800 work?+
The blend supplies a complete set of essential and non‑essential amino acids directly into the bloodstream. These amino acids act as building blocks for protein synthesis, replenish nitrogen stores, and support metabolic pathways such as gluconeogenesis, thereby sustaining tissue repair and energy production when oral intake is not possible.
What is the usual dose of Oliclinomel N8-800?+
The prescribed dose of Oliclinomel N8-800 is determined by the treating clinician based on the patient’s weight, clinical condition, renal and hepatic function, and nutritional requirements. The healthcare professional calculates the appropriate infusion rate and total daily amount.
Is Oliclinomel N8-800 safe during pregnancy or breastfeeding?+
Safety data for Oliclinomel N8-800 in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the prescribing physician.
How do I order Oliclinomel N8-800 from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.
How does Oliclinomel N8-800 compare with other parenteral amino acid products?+
Oliclinomel N8-800 offers a balanced profile of ten essential amino acids, matching or exceeding the composition of many standard parenteral amino acid formulations. Its EU‑origin manufacturing ensures compliance with stringent quality standards, and it is designed for compatibility with common parenteral nutrition regimens.
What are the storage and handling requirements for Oliclinomel N8-800?+
The solution must be stored refrigerated at 2‑8 °C, protected from light, and should never be frozen or shaken. Keep the container in its original packaging until use and discard any product that appears discolored or contains particles.
How is Oliclinomel N8-800 administered?+
Oliclinomel N8-800 is administered intravenously, typically via a central or peripheral venous catheter. The infusion rate is set by the clinician based on the patient’s nutritional plan and monitored continuously for tolerance and metabolic response.
What are the most serious risks associated with Oliclinomel N8-800?+
Serious risks include anaphylactic reactions, severe metabolic acidosis, renal dysfunction, and thrombophlebitis. Patients should be closely monitored for signs of allergic response, changes in blood pH, kidney function, and any vascular complications during and after infusion.
Who should not receive Oliclinomel N8-800?+
Patients with known hypersensitivity to any of the amino acids in the formulation, those with uncontrolled hyperammonemia or urea‑cycle disorders, and individuals for whom a compatible intravenous solution is unavailable should not be given Oliclinomel N8-800.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin
Route
Intravenous Use
Manufacturer
Baxter Sa
Origin
EU